Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Caballero-Rabasco MA"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins.
Autorzy:
Eguía J; Laboratori de Referència de Catalunya SA, El Prat de Llobregat, Spain.; Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.
Caballero-Rabasco MA; Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.; Department of Pediatrics, Hospital del Mar, Barcelona, Spain.
Cos ML; Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.; Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.
Grau S; Department of Pharmacy, Hospital del Mar, Barcelona, Spain.
Mellibovsky L; Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.; Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.
Villegas E; Laboratori de Referència de Catalunya SA, El Prat de Llobregat, Spain.; Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.
Blasco F; Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.; Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain.; Laboratory of Immunology, Department of Pathology, Hospital del Mar, Barcelona.
Lemus A; Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.; Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain.
Crespo M; Department of Nephrology, Hospital del Mar, Barcelona, Spain.
Padilla E; Laboratori de Referència de Catalunya SA, El Prat de Llobregat, Spain.
Gimeno R; Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.; Laboratory of Immunology, Department of Pathology, Hospital del Mar, Barcelona.; Immunity and Infection, Hospital del Mar Medical Research Institute, Barcelona, Spain.; Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.
Pokaż więcej
Źródło:
Immunology [Immunology] 2022 Aug; Vol. 166 (4), pp. 539-542. Date of Electronic Publication: 2022 May 31.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
SARS-CoV-2*
Antibodies, Neutralizing ; Antibodies, Viral/therapeutic use ; Humans ; Immunoglobulins/therapeutic use ; Spike Glycoprotein, Coronavirus
Raport
Tytuł:
Smartphone App for monitoring Asthma in children and adolescents.
Autorzy:
Mayoral K; Health Services Research Group, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.; Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública CIBERESP, Madrid, Spain.
Garin O; Health Services Research Group, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain. .; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública CIBERESP, Madrid, Spain. .; Pompeu Fabra University UPF, Barcelona, Spain. .
Caballero-Rabasco MA; Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Pediatric Allergy and Pulmonology Unit, Pediatric Service, Hospital del Mar, Barcelona, Spain.
Praena-Crespo M; Centro de Salud la Candelaria, Servicio Andaluz de Salud, Seville, Spain.; Grupo de Vías Respiratorias de la Asociación Española de Pediatras de Atención Primaria (AEPAP), Madrid, Spain.
Bercedo A; Grupo de Vías Respiratorias de la Asociación Española de Pediatras de Atención Primaria (AEPAP), Madrid, Spain.; Centro de Salud Dobra, Servicio Cántabro de Salud, Cantabria, Spain.
Hernandez G; Grupo de Vías Respiratorias de la Asociación Española de Pediatras de Atención Primaria (AEPAP), Madrid, Spain.; CAP Vila Olimpica, Parc Sanitari Pere Virgili, Barcelona, Spain.
Castillo J; Grupo de Vías Respiratorias de la Asociación Española de Pediatras de Atención Primaria (AEPAP), Madrid, Spain.; Pediatric Pneumology Unit, Pediatric Service, Hospital Infantil Universitario Miguel Servet, Zaragoza, Spain.
Lizano Barrantes C; Health Services Research Group, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.; Pompeu Fabra University UPF, Barcelona, Spain.; University of Costa Rica, San José, Costa Rica.
Pardo Y; Health Services Research Group, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública CIBERESP, Madrid, Spain.; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Ferrer M; Health Services Research Group, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain. .; Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. .; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública CIBERESP, Madrid, Spain. .
Pokaż więcej
Corporate Authors:
ARCA group
Źródło:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2021 Nov; Vol. 30 (11), pp. 3127-3144. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Asthma*
Mobile Applications*
Telemedicine*
Adolescent ; Child ; Humans ; Quality of Life/psychology ; Smartphone
Czasopismo naukowe
Tytuł:
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma.
Autorzy:
Nieto García A; Pediatric Pulmonology and Allergy Unit, Hospital Universitari i Politècnic La Fe, Health Research Institute La Fe, Valencia, Spain.
Garriga-Baraut T; Pediatric Allergy Unit, Hospital Universitari Vall d'Hebron. Grup d'Investigació 'Creixement i Desenvolupament', Institut de Recerca de l'Hospital Universitari Vall d'Hebron (VHIR), Barcelona, Spain.
Plaza Martín AM; Allergy and Clinical Immunology Department, Hospital Maternoinfantil Sant Joan de Déu, Barcelona, Spain.
Nieto Cid M; Pediatric Pulmonology and Allergy Unit, Hospital Universitari i Politècnic La Fe, Health Research Institute La Fe, Valencia, Spain.; Now with Allergy Service, Hospital Universitario de La Plana, Villarreal, Spain.
Torres Borrego J; Pediatric Allergy and Pulmonology Unit, Hospital Universitario Reina Sofía, Córdoba, Spain.
Folqué Giménez MDM; Allergy and Clinical Immunology Department, Hospital Maternoinfantil Sant Joan de Déu, Barcelona, Spain.
Lozano Blasco J; Allergy and Clinical Immunology Department, Hospital Maternoinfantil Sant Joan de Déu, Barcelona, Spain.
Bosque García M; Pediatric Allergy and Pulmonology Unit, Hospital de Sabadell - Corporació Universitaria Parc Taulí, Sabadell, Spain.
Moreno-Galarraga L; Pediatric Pulmonology Unit, Complejo Hospitalario de Navarra. IdiSNA Health Research Institute, Pamplona, Spain.
Tortajada-Girbés M; Pediatric Allergy and Pneumology Unit, Hospital Universitari Dr. Peset, Valencia, Spain. Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, Valencia, Spain.
Rivas Juesas C; Pediatric Pulmonology and Allergy Unit, Hospital de Sagunto, Sagunto, Spain.
Penín Antón M; Pediatrics Service, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
Caballero-Rabasco MA; Pediatric Pulmonology and Allergy Unit, Hospital del Mar, Barcelona, Spain.
Gaboli M; Pediatric Pulmonology and Allergy Unit, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
López Neyra A; Pediatric Pulmonology Unit, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Navarro Morón J; Pediatrics Service, Hospital Costa del Sol, Marbella, Spain.
Freixa Benavente A; Pediatric Allergy Unit, Hospital Universitari Vall d'Hebron. Grup d'Investigació 'Creixement i Desenvolupament', Institut de Recerca de l'Hospital Universitari Vall d'Hebron (VHIR), Barcelona, Spain.
Valdesoiro Navarrete L; Pediatric Allergy and Pulmonology Unit, Hospital de Sabadell - Corporació Universitaria Parc Taulí, Sabadell, Spain.
Ballester Asensio E; Pediatric Allergy and Pneumology Unit, Hospital Universitari Dr. Peset, Valencia, Spain. Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, Valencia, Spain.
Sanz Santiago V; Pediatric Pulmonology Unit, Hospital Universitario Infantil Niño Jesús, Madrid, Spain.
Romero García R; Pediatric Pulmonology and Allergy Unit, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Gimeno Díaz de Atauri Á; Pediatric Pulmonology and Allergy Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
Valenzuela Soria A; Pediatric Pulmonology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Sánchez Mateos M; Pediatric Pulmonology Unit, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
Batlles Garrido J; Pediatric Pulmonology and Allergy Unit, Hospital Universitario Torrecárdenas, Almería, Spain.
Andrés Martín A; Pediatric Pulmonology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Campos Alonso E; Pediatrics Service, Hospital Comarcal Virgen de la Merced, Osuna, Spain.
Aragón Fernández C; Pediatrics Service, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Spain.
Vázquez Rodríguez E; Pediatric Pulmonology Unit, Hospital Universitario Nuestra Señora de Valme, Sevilla, Spain.
Martínez Pardo L; Pediatric Pulmonology Unit, Complejo Hospitalario de Jaén, Jaén, Spain.
Del-Río Camacho G; Pediatrics Service, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Mazón Ramos Á; Pediatric Pulmonology and Allergy Unit, Hospital Universitari i Politècnic La Fe, Health Research Institute La Fe, Valencia, Spain.
Pokaż więcej
Źródło:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2021 Jul; Vol. 32 (5), pp. 980-991. Date of Electronic Publication: 2021 Mar 20.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Asthma*/drug therapy
Anti-Asthmatic Agents/*therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Omalizumab/*therapeutic use
Anti-Asthmatic Agents/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects ; Child ; Humans ; Omalizumab/adverse effects ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Immunofluorescence Analysis as a Diagnostic Tool in a Spanish Cohort of Patients with Suspected Primary Ciliary Dyskinesia.
Autorzy:
Baz-Redón N; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Obstetrics, Gynecology, Preventative Medicine and Public Health. Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Rovira-Amigo S; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Obstetrics, Gynecology, Preventative Medicine and Public Health. Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.; Department of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Fernández-Cancio M; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Castillo-Corullón S; Pediatric Pulmonology Unit, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
Cols M; Pediatric Pulmonology Department and Cystic Fibrosis Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain.
Caballero-Rabasco MA; Pediatric Pulmonology Unit, Department of Pediatrics, Hospital del Mar, 08003 Barcelona, Spain.
Asensio Ó; Pediatric Pulmonology Unit, Hospital Parc Taulí de Sabadell, 08208 Sabadell, Spain.
Martín de Vicente C; Pediatric Pulmonology Unit, Hospital Miguel Servet, 50009 Zaragoza, Spain.
Martínez-Colls MDM; Pediatric Pulmonology Unit, Hospital Germans Trias i Pujol, 08916 Badalona, Spain.
Torrent-Vernetta A; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Obstetrics, Gynecology, Preventative Medicine and Public Health. Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.; Department of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
de Mir-Messa I; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Gartner S; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Iglesias-Serrano I; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Díez-Izquierdo A; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Polverino E; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Pneumology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Amengual-Pieras E; Department of Pediatrics, Hospital Universitario Son Llàtzer, 07198 Palma de Mallorca, Spain.
Amaro-Rodríguez R; Pneumology Department, Hospital Clínic, 08036 Barcelona, Spain.
Vendrell M; Pneumology Department, Hospital Josep Trueta, 17007 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Universitat de Girona, 17190 Girona, Spain.; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Mumany M; Pediatric Pulmonology Unit, Consorci Sanitari de Terrassa, 08191 Terrassa, Spain.
Pascual-Sánchez MT; Pediatric Pulmonology Unit, Hospital Universitari Sant Joan de Reus, 43204 Tarragona, Spain.
Pérez-Dueñas B; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Reula A; Grupo de Biomedicina Molecular, Celular y Genómica, IIS La Fe, 46026 Valencia, Spain.; Department of Paediatrics, Obstetrics and Gynecology, Universitat de Valencia, 46010 Valencia, Spain.
Escribano A; Pediatric Pulmonology Unit, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.; Department of Paediatrics, Obstetrics and Gynecology, Universitat de Valencia, 46010 Valencia, Spain.; UCIM, Rare Respiratory Diseases Research Group, Instituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.
Dasí F; Department of Paediatrics, Obstetrics and Gynecology, Universitat de Valencia, 46010 Valencia, Spain.; UCIM, Rare Respiratory Diseases Research Group, Instituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.
Armengot-Carceller M; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Grupo de Biomedicina Molecular, Celular y Genómica, IIS La Fe, 46026 Valencia, Spain.; Department of Paediatrics, Obstetrics and Gynecology, Universitat de Valencia, 46010 Valencia, Spain.; Otorhinolaryngology Department, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Garrido-Pontnou M; Department of Pathology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Camats-Tarruella N; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Moreno-Galdó A; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; Department of Pediatrics, Obstetrics, Gynecology, Preventative Medicine and Public Health. Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.; Department of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Nov 09; Vol. 9 (11). Date of Electronic Publication: 2020 Nov 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies